Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of GDC-0449 in Patients With Advanced Chondrosarcomas

NCT01267955 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT01267955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01267955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of GDC-0449 in Patients With Advanced Chondrosarcomas
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Active, not recruiting
Start date
December 21, 2010
Completion date
July 21, 2027
Enrollment
45 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

clear cell chondrosarcoma, dedifferentiated chondrosarcoma, locally advanced chondrosarcoma, mesenchymal chondrosarcoma, metastatic chondrosarcoma, primary central chondrosarcoma, unresectable primary central chondrosarcoma